EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Orexins mitigate obesity‐associated dysfunctions in mice

Anne Blais iD, Isabelle Denis, Mireille Andriamihaja, Valérie Gratio, Gaelle Champeil-Potokar, Samira Laouirem, Anais Chassac, Anne Couvelard, Valérie Paradis, Thierry Voisin, Anne-Marie Davila, Alain Couvineau

Obesity · 2024

DOI: 10.1002/oby.24120 ↗

At a glance

Journal article in Obesity, 2024. Written by Anne Blais and 11 co-authors. Institution: UMR-PNCA, Université Paris-Saclay, AgroParisTech, Palaiseau, France. Major MEDLINE topics: Orexins, Obesity, Mice, Inbred C57BL, Diet, High-Fat. Cited 3 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National League Against Cancer, French National Cancer Institute, Ligue Contre le Cancer.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Obesity is a chronic disease that affects more than 400 million adults with severe comorbidities. The search for new treatments to reduce its negative consequences is necessary. Orexins are hypothalamic neuropeptides involved in various physiological processes related to obesity. The aim of this study was to investigate the consequences of chronic orexin‐A treatment in mouse models.

Methods

Female wild‐type C57BL/6 mice that were obesity‐prone or obesity‐resistant and mice that were deficient for orexin receptors were fed with a high‐fat diet. Glucose tolerance, indirect calorimetry, expression of brain neuropeptides and receptors, microglial activation, and microbiota were determined to evaluate the role of orexins on metabolic flexibility.

Results

Orexin‐A reduces weight gain in obesity‐prone mice. This reduction is associated with a decrease in body fat, food intake, steatosis, and insulin resistance, as well as alterations of intestinal microbiota composition. A decreased expression of orexin receptors and neuropeptides involved in food intake was also observed in the hypothalamus.

Conclusions

Our data support the notion that orexin receptor signaling is involved in different aspects of energy metabolism and can mitigate several dysfunctions associated with obesity, suggesting that orexin receptors can represent new targets for obesity treatment.

Subjects

MeSH terms (MEDLINE)

OrexinsObesityMice, Inbred C57BLDiet, High-FatHypothalamusInsulin ResistanceEnergy MetabolismOrexin ReceptorsGastrointestinal MicrobiomeAnimalsMiceFemaleWeight GainAdipose TissueEatingSignal TransductionMice, KnockoutDisease Models, Animal

Substances

OrexinsOrexin Receptors

Authors and institutions

  • UMR-PNCA, Université Paris-Saclay, AgroParisTech, Palaiseau, France.
  • INSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Paris, France.

ORCID profiles: Anne Blais

Funding

  • National League Against Cancer
  • French National Cancer Institute
  • Ligue Contre le Cancer

Cite

APA

Blais, A., Denis, I., Andriamihaja, M., Gratio, V., Champeil-Potokar, G., Laouirem, S., Chassac, A., Couvelard, A., Paradis, V., Voisin, T., Davila, A. M., & Couvineau, A. (2024). Orexins mitigate obesity‐associated dysfunctions in mice. Obesity. https://doi.org/10.1002/oby.24120

Vancouver

Blais A, Denis I, Andriamihaja M, Gratio V, Champeil-Potokar G, Laouirem S, et al. Orexins mitigate obesity‐associated dysfunctions in mice. Obesity. 2024. doi:10.1002/oby.24120

BibTeX
@article{Blais2024,
  author = {Blais, Anne and Denis, Isabelle and Andriamihaja, Mireille and Gratio, Valérie and Champeil-Potokar, Gaelle and Laouirem, Samira and Chassac, Anais and Couvelard, Anne and Paradis, Valérie and Voisin, Thierry and Davila, Anne-Marie and Couvineau, Alain},
  title = {Orexins mitigate obesity‐associated dysfunctions in mice},
  journal = {Obesity},
  year = {2024},
  doi = {10.1002/oby.24120}
}
Start for free →